| SciPort RLP

2019 - 2022

EBRUC STUDIE

PD Dr. Hendrik

2019 - 2040

Tumorantigene bei AML/MDS/MM (#1168)

Dr. Eva Maria

2019 - 2023

A Phase I/II clinical trial for TCR modified T cells MDG1011in HR myeloid and lymphatic neoplasms (#799)

Dr. Eva Maria

2019 - 2040

ADVANCE II (#512)

Dr. Eva Maria

2019 - 2022

V114 in recipients of allogeneic hematopoietic stem cell transplant (#796)

Dr. Daniel

2019 - 2021

Patientenorientierte Tumoranalytik

PD Dr. Thomas

2019 - 2022

NeurodegX

PD Dr. Kristina

2019 - 2021

AURIGA / An observationAl stUdy pRogram to InvestiGate the effectiveness of intravitreal Aflibercept in diabetic macular edema and/or macular edema secondary to retinal vein occlusion in a real world setting (Ein Beobachtungsstudienprogramm zur Untersuchung der Effektivität von intravitrealem Aflibercept bei diabetischem Makulaödem und/oder Makulaödem infolge eines retinalen Venenverschlusses in der klinischen Praxis)

PD Dr. Dr. Katrin

2019 - 2022

A PROSPECTIVE CONTROLLED CLINICAL STUDY TO EVALUATE THE SAFETY AND PERFORMANCE OF THE HOYA SURGICAL OPTICS VIVINEX® GEMETRIC™ PRELOADED INTRAOCULAR LENS

PD Dr. Dr. Katrin

2019 - 2021

LIGHTSITE II - A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects with Dry Age-Related Macular Degeneration (AMD)

PD Dr. Dr. Katrin,
Dr. Bert

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz